Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 7;6(24):15794-15803.
doi: 10.1021/acsomega.1c01182. eCollection 2021 Jun 22.

N-Aryl-3,4-dihydroisoquinoline Carbothioamide Analogues as Potential Urease Inhibitors

Affiliations

N-Aryl-3,4-dihydroisoquinoline Carbothioamide Analogues as Potential Urease Inhibitors

Fayaz Ali et al. ACS Omega. .

Abstract

N-Aryl-3,4-dihydroisoquinoline carbothioamide analogues 1-22 were synthesized by a simple one-step reaction protocol and subjected to in vitro urease inhibition studies for the first time. All compounds 1-22 were found active and showed significant to moderate urease inhibitory potential. Specifically, analogues 1, 2, 4, and 7 were identified to be more potent (IC50 = 11.2 ± 0.81-20.4 ± 0.22 μM) than the standard thiourea (IC50 = 21.7 ± 0.34 μM). The structure-activity relationship showed that compounds bearing electron-donating groups showed superior activity. Molecular docking study on the most active derivatives revealed a good protein-ligand interaction profile against the corresponding target with key interactions, including hydrogen bonding, hydrophobic, and π-anion interactions.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Rationale of the present research work.
Scheme 1
Scheme 1. Synthesis of N-Aryl-3,4-Dihydroisoquinoline Carbothioamide Analogues 1–22
Figure 2
Figure 2
Structure–activity relationship of compounds 1–5.
Figure 3
Figure 3
Structure–activity relationship of compounds 6–8.
Figure 4
Figure 4
Structure–activity relationship of compounds 911.
Figure 5
Figure 5
Structure–activity relationship of compounds 12–19
Figure 6
Figure 6
Structure–activity relationship of compounds 11–13
Figure 7
Figure 7
Binding mode of the synthesized compounds. (A) Surface representation of the enzyme with embedded ligands; (B) Binding mode of compound 2; (C) for compound 4; and (D) for compound 7; and (E) for compound 1. The double sided arrow indicates pi-H bonds.

Similar articles

Cited by

References

    1. Qin Y.; Cabral J. M. Kinetic studies of the urease-catalyzed hydrolysis of urea in a buffer-free system. Biotechnol. Appl. Biochem. 1994, 49, 217–240. 10.1007/BF02783059. - DOI - PubMed
    1. Lodhi M. A.; Shams S.; Choudhary M. I.; Lodhi A.; Ul-Haq Z.; Jalil S.; Nawaz S. A.; Khan K. M.; Iqbal S.; Rahman A. U. Structural basis of binding and rationale for the potent urease inhibitory activity of biscoumarins. Bio. Med. Res. int. 2014, 1–12. 10.1155/2014/935039. - DOI - PMC - PubMed
    1. Pervez H.; Iqbal M. S.; Tahir M. Y.; Nasim F. U. H.; Choudhary M. I.; Khan K. M. In vitro cytotoxic, antibacterial, antifungal and urease inhibitory activities of some N4-substituted isatin-3-thiosemicarbazones. J. Enzymem Inhib. Med. Chem. 2008, 23, 848–854. 10.1080/14756360701746179. - DOI - PubMed
    1. Arshad T.; Khan K. M.; Rasool N.; Salar U.; Hussain S.; Asghar H.; Ashraf M.; Wadood A.; Riaz M.; Perveen S.; Taha M.; Ismail N. H. 5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α-glucosidase and urease enzymes. Bioorg. Chem. 2017, 72, 21–31. 10.1016/j.bioorg.2017.03.007. - DOI - PubMed
    1. Ara R.; Ashiq U.; Mahroof-Tahir M.; Maqsood Z. T.; Khan K. M.; Lodhi M. A.; Choudhary M. I. Chemistry, urease inhibition, and phytotoxic studies of binuclear vanadium (IV) complexes. Chem. Biodiversity 2007, 4, 58–71. 10.1002/cbdv.200790007. - DOI - PubMed